# Comparative Study of Coadministered Ceftaroline Fosamil and NXL104 vs. Intravenous Doripenem in Adult Subjects With Complicated Urinary Tract Infections

> **NCT01281462** · PHASE2 · COMPLETED · sponsor: **Forest Laboratories** · enrollment: 217 (actual)

## Conditions studied

- Urinary Tract Infections

## Interventions

- **DRUG:** Ceftaroline fosamil and NXL104 (q8h)
- **DRUG:** Ceftaroline fosamil and NXL104 (q12h)
- **DRUG:** Doripenem
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01281462
- **Lead sponsor:** Forest Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** 2012-03
- **Final completion:** 2012-07
- **Target enrollment:** 217 (ACTUAL)
- **Last updated:** 2014-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01281462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01281462, "Comparative Study of Coadministered Ceftaroline Fosamil and NXL104 vs. Intravenous Doripenem in Adult Subjects With Complicated Urinary Tract Infections". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01281462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*